The Barricaid® device has been successfully implanted in patients since 2008. As part of its clinical introduction, the Barricaid has been studied in several clinical trials, which have led to a series of publications in leading medical journals and over ninety scientific presentations at international medical conferences. In December 2010, over twenty European hospitals initiated a randomized controlled trial, looking to demonstrate the clear benefit of Barricaid Anular Closure compared to the gold standard procedure (discectomy alone), in patients at highest risk of a new herniation. Two-year clinical results from 554 patients are expected to get published soon.
J Neurol Surg A 2015;76:211-218. Effect of Anular Closure on Disk Height Maintenance and Reoperated Recurrent Herniation Following Lumbar Diskectomy: Two-Year Data. D Ledic, D Vukas, G Grahovac, M Barth, GJ Bouma, M Vilendecic